klini^ko ispituvawe na terapiskata efikasnost, podnoslivost i

Clinical trial on terapeutic efficacy, tolerability and safety of peroral solutions Varumin 1 and 2 (Interevrogeneks)
in a combined treatment with polyvitamin – antioxidative therapy in patients with biologicaly
(PCR) detected HPV infection of high-risk type, with or without biopticaly verified CIN I
Analysis with Wilcoxon Matched Pairs Test did not present statistical significant differences
between HPV PCR typization on the second and the third check-up among patients treated
with placebo. (T = 7,00 Z = 0,733 p = 0,4630 ).
4. CROSS ANALISYS BETWEEN GROUPS ACCORDING TO COLPOSCOPIC
FINDINGS ON FIRST CHECK-UP
Table 7. Distribution of patients according to colposcopic findings on first check up
colposcopic findings investigated agent placebo
A % A %
normal findings ( 0 ) 13 28.26 12 28.57
suspicious findings ( 1 ) 14 30.44 13 30.95
abnormal findings ( 2 ) 19 41.30 17 40.48
total 46 100 42 100
Chart 7. Distribution of patients according to colposcopic findings on first check up
20
18
16
14
12
10
8
6
4
2
0
13
14
19
University Gynecology and Obstetrics Clinic, Vodnjanska bb, University St. Cyrillus and Methodius, Skopje,
Macedonia
12
13
investigated agent placebo
normal suspicious abnormal
Analysis with Mann-Whitney U Test did not present statistical significant differences according
to colposcopic findings between groups on the first check-up. (Z = - 0,062 p = 0,950)
17
30